Молимо вас користите овај идентификатор за цитирање или овај линк до ове ставке:
https://scidar.kg.ac.rs/handle/123456789/9297
Назив: | THYRPAN-TM Prototype: New System for Online Telemonitoring of Patients with Thyroid Carcinoma during the Treatment with a High Dose of Radioiodine |
Аутори: | Matovic, Milovan ![]() ![]() Jeremic M. ![]() Jankovic, Slobodan ![]() ![]() Urošević V. ![]() ![]() Ravlic M. Vlajkovic M. |
Датум издавања: | 2015 |
Сажетак: | © 2015, Mary Ann Liebert, Inc. Background: Our team devised a real-time telemonitoring system (THYRPAN-TM) for measurement of the radiation exposure rate during the hospitalization of patients treated with high doses of radioiodine in the special premises with restricted access (restricted area [RA]). Subjects and Methods: The THYRPAN-TM prototype was tested for stability, efficacy, and linearity in a 32-day measurement of a 110a MBq <sup>131</sup>I source. Furthermore, it was tested on 15 patients with differentiated thyroid carcinoma who stayed in the RA for 3 days, following their radioiodine treatment. Results: Minor deviation from the theoretical values was detected when the <sup>131</sup>I source was measured by the THYRPAN-TM, but only at the beginning of the measurement (7.20%). Conclusions: THYRPAN-TM is a stable, user-friendly detection system for the measurement of the exposure rate following radioiodine administration. It enables the telemonitoring of patients, as well as real-time and online measurement of the whole-body burden of <sup>131</sup>I. |
URI: | https://scidar.kg.ac.rs/handle/123456789/9297 |
Тип: | article |
DOI: | 10.1089/tmj.2014.0146 |
ISSN: | 1530-5627 |
SCOPUS: | 2-s2.0-84940666951 |
Налази се у колекцијама: | Faculty of Medical Sciences, Kragujevac |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
10.1089-tmj.2014.0146.pdf | 319.12 kB | Adobe PDF | ![]() View/Open |
This item is licensed under a Creative Commons License